According to The World Health Organization’s survey, an average 50 percent of those suffering from chronic illnesses such as diabetes and hypertension do not hold on to their medication therapies, despite of their worsening condition. Adhering to this global problem, Adherium has developed Smartinhaler, a clinically proven asthma and COPD medication adherence solution.

The technology platform empowers patients, caregivers, researchers and physicians for accurate medication monitoring and reminders. Smartinhaler medication sensors keep a track of every preventer and reliever medications taken. If the user forgets to take the medication as prescribed, the Smartinhaler device provides a cautious alert to the user. The bluetooth feature allows automatic wireless transmission of medication use and adherence data to apps and the cloud. It can also alert users when it’s time to take their preventative medication.

After Smartinhaler’s first clinical trial in 2003, the company expanded its technology platform and Smartinhaler product range.